Press release

Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities

– $6 Million USD in Funding Will Help Address Health Disparities Among Indigenous Communities with a Focus on HIV and Viral Hepatitis – FOSTER CITY,

articleGilead Sciences, Inc.July 23, 20234/company/gilead-sciences-inc/news/gilead-sciences-announces-its-largest-commitment-to-health-equity-for-australian-and
Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities

About this update from Gilead Sciences, Inc.

[{"type":"text","content":"\n– $6 Million USD in Funding Will Help Address Health Disparities Among Indigenous Communities with a Focus on HIV and Viral Hepatitis –\n\n\n FOSTER CITY, Calif.--(BUSINESS WIRE)--\nGilead Sciences Inc. (Nasdaq: GILD) today announced its largest commitment to health equity for Australian and Canadian Indigenous communities. The initiative will support programs addressing societal barriers to care that persistently contribute to the transmission of HIV and viral hepatitis within Indigenous communities.\n\n\nGilead is in discussions with two Indigenous-led organizations, the Lowitja Institute in Australia and CAAN Communities, Alliances & Networks in Canada, to create the new $6 million USD grant program, with funding divided equally between the two countries and invested over three years. The grant program will provide financial support to frontline organizations and initiatives.\n\n\nThis program is a targeted effort to help address the disparities in health outcomes impacting Indigenous communities, resulting from the ongoing effects of colonialization in each country. In comparison to non-Indigenous people in each country, Indigenous Peoples in Australia and Canada experience a higher incidence of HIV and viral hepatitis infections and increased barriers to diagnosis and treatment.i, ii\n\n\n“We recognize that the Indigenous communities in both Australia and Canada have unique healthcare needs,” said Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. \"Gilead's new funding program will help promote engagement in HIV and viral hepatitis care by supporting culturally appropriate solutions that address these needs, while enabling Indigenous people to continue advocating for the care of their communities.\"\n\n\nBy listening to and working with Indigenous-led organizations, Gilead believes this commitment can translate to meaningful support of innovative and culturally appropriate projects that address the disproportionate rate of HIV and viral hepatitis in Indigenous communities.\n\n\nGilead’s funding commitment underscores the company’s unique efforts to increase health equity and help end the HIV epidemic globally through robust community partnerships and philanthropy. In 2022 alone, the Gilead Foundation and Gilead Corporate Giving donated a combined nearly $300 million globally. Other corporate giving ...

More updates from Gilead Sciences, Inc.